Table 1. Prevalence of CVD risk factors determined as per standard of care in total study population (N = 372).
| Categories | N (%; 95%CI) | |
|---|---|---|
| Demographic factors | ||
| Mean age in years(SD) | 33.5 (6.1) | |
| Age groups (years) N = 372 | 20–29 | 113 (30.4; 25.8–35.4) |
| 30–39 | 194 (52.2; 46.9–57.3) | |
| 40–49 | 65 (17.5; 13.8–21.8) | |
| Traditional CVD risk factors | ||
| BMI Median (IQR) | 27.3 (23.2–33.1) | |
| BMI categories (kg/m2) N = 367 | <25 | 139 (37.9; 32.9–43.1) |
| 25–29 | 95 (25.9; 21.5–30.7) | |
| 30–39 | 133 (36.2; 31.4–41.4) | |
| 40–49 | 20 (5.5; 3.5–8.4) | |
| Systolic blood pressure Mean (SD) | 115.7 (15.6) | |
| Systolic blood pressure categories (mmHg) N = 368 | <130 | 315 (85.6; 81.5–88.9) |
| 130–139 | 27 (7.3; 4.9–10.6) | |
| ≥140 | 26 (7.1; 4.8–10.3) | |
| Diastolic blood pressure Mean (SD) | 73.3 (11.5) | |
| Diastolic blood pressure categories (mmHg) N = 202 | <85 | 169 (83.7; 77.8–88.5) |
| 85–89 | 15 (7.4; 4.2–11.9) | |
| ≥90 | 18 (8.9; 5.4–13.7) | |
| HIV-related factors | ||
| ART Regimen (type) N = 372 | AZT/3TC+ LPV/r | 4 (1.1; 0.4–2.9) |
| EFV/FTC/TDF | 362 (97.3; 94.9–98.6) | |
| FTC/TDF + LPV/r | 5 (1.3; 0.5–3.3) | |
| NVP+FTC/TDF | 1 (0.3; 0.01–1.7) | |
| Duration of Current ART Regimen (years) Mean(SD) | 4.3 (2.2) | |
| Duration of Current ART Regimen (years) Categories | 1–4 | 270 (72.6; 67.7–76.9) |
| >4 | 102 (27.4; 23.0–32.3) | |
| CD4 Count (cells/iu) Median (IQR) | 803 (558–1030) | |
| CD4 count (cells/iu) Categories N = 371 | <500 | 68 (18.3; 14.6–22.7) |
| ≥500 | 303 (81.7; 77.3–85.4) | |
| Viral Load (cp/ml) Mean(Range) | 768 (0–113 559) | |
| Viral load (cp/ml) Categories N = 368 | ≥200 | 18 (4.9; 3.0–7.8) |
| <200 | 350 (95.1; 92.2–96.9) | |
Key: SD = Standard deviation, IQR = Interquartile range, CI = confidence interval, AZT = Zidovudine, 3TC = lamivudine, EFV = Efavirenz, FTC = Emtricitabine, TDF = Tenofovir disoproxil fumarate, LPV/r = Lopinavir/Ritonavir, NVP = Nevirapine.